BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29360538)

  • 1. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
    Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
    Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.
    Zhou J; Liu M; Sun H; Feng Y; Xu L; Chan AWH; Tong JH; Wong J; Chong CCN; Lai PBS; Wang HK; Tsang SW; Goodwin T; Liu R; Huang L; Chen Z; Sung JJ; Chow KL; To KF; Cheng AS
    Gut; 2018 May; 67(5):931-944. PubMed ID: 28939663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis.
    Yu Z; Gao YQ; Feng H; Lee YY; Li MS; Tian Y; Go MY; Yu DY; Cheung YS; Lai PB; Yu J; Wong VW; Sung JJ; Chan HL; Cheng AS
    Gut; 2014 Nov; 63(11):1793-804. PubMed ID: 24440987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients.
    Feng H; Yu Z; Tian Y; Lee YY; Li MS; Go MY; Cheung YS; Lai PB; Chan AM; To KF; Chan HL; Sung JJ; Cheng AS
    J Hepatol; 2015 May; 62(5):1100-11. PubMed ID: 25500144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma.
    Wu GQ; Xie D; Yang GF; Liao YJ; Mai SJ; Deng HX; Sze J; Guan XY; Zeng YX; Lin MC; Kung HF
    Int J Cancer; 2009 Dec; 125(11):2631-42. PubMed ID: 19672860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis.
    Feng H; Cheng AS; Tsang DP; Li MS; Go MY; Cheung YS; Zhao GJ; Ng SS; Lin MC; Yu J; Lai PB; To KF; Sung JJ
    J Clin Invest; 2011 Aug; 121(8):3159-75. PubMed ID: 21747169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma.
    Ng SS; Cheung YT; An XM; Chen YC; Li M; Li GH; Cheung W; Sze J; Lai L; Peng Y; Xia HH; Wong BC; Leung SY; Xie D; He ML; Kung HF; Lin MC
    J Natl Cancer Inst; 2007 Jun; 99(12):936-48. PubMed ID: 17565152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of CDK20 Protein in Carcinogenesis.
    Chivukula S; Malkhed V
    Curr Drug Targets; 2023; 24(10):790-796. PubMed ID: 37469151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma.
    Sun H; Yang W; Tian Y; Zeng X; Zhou J; Mok MTS; Tang W; Feng Y; Xu L; Chan AWH; Tong JH; Cheung YS; Lai PBS; Wang HKS; Tsang SW; Chow KL; Hu M; Liu R; Huang L; Yang B; Yang P; To KF; Sung JJY; Wong GLH; Wong VWS; Cheng ASL
    Nat Commun; 2018 Dec; 9(1):5214. PubMed ID: 30523261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase.
    Yu Z; Feng H; Sun X; Zhuo Y; Li M; Zhou Z; Huang L; Jiang Y; Zhu X; Zhang X; Le F; Zheng C; Cheng AS; Gao Y
    Sci Rep; 2018 Mar; 8(1):3891. PubMed ID: 29497076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterisation of cell cycle-related kinase (CCRK) in colorectal cancer carcinogenesis.
    An X; Ng SS; Xie D; Zeng YX; Sze J; Wang J; Chen YC; Chow BK; Lu G; Poon WS; Kung HF; Wong BC; Lin MC
    Eur J Cancer; 2010 Jun; 46(9):1752-61. PubMed ID: 20466538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.
    Yu Z; Feng H; Zhuo Y; Li M; Zhu X; Huang L; Zhang X; Zhou Z; Zheng C; Jiang Y; Le F; Yu DY; Cheng AS; Sun X; Gao Y
    Cell Oncol (Dordr); 2020 Dec; 43(6):1129-1145. PubMed ID: 32623699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer.
    Wang J; Zhang R; Lin Z; Zhang S; Chen Y; Tang J; Hong J; Zhou X; Zong Y; Xu Y; Meng R; Xu S; Liu L; Zhang T; Yang K; Dong X; Wu G
    J Hematol Oncol; 2020 Jul; 13(1):99. PubMed ID: 32690037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activity.
    Wohlbold L; Larochelle S; Liao JC; Livshits G; Singer J; Shokat KM; Fisher RP
    Cell Cycle; 2006 Mar; 5(5):546-54. PubMed ID: 16552187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-intrinsic cell cycle-related kinase drives immunosuppression to promote tumorigenesis.
    Zhou J; Wang H; Shu T; Wang J; Yang W; Li J; Ding L; Liu M; Sun H; Wong J; Lai PB; Tsang SW; Ward SE; Chow KL; Sung JJ; Sze-Lok Cheng A
    iScience; 2023 Oct; 26(10):107626. PubMed ID: 37731616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCRK depletion inhibits glioblastoma cell proliferation in a cilium-dependent manner.
    Yang Y; Roine N; Mäkelä TP
    EMBO Rep; 2013 Aug; 14(8):741-7. PubMed ID: 23743448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Cycle-Related Kinase (CCRK) regulates ciliogenesis and Hedgehog signaling in mice.
    Snouffer A; Brown D; Lee H; Walsh J; Lupu F; Norman R; Lechtreck K; Ko HW; Eggenschwiler J
    PLoS Genet; 2017 Aug; 13(8):e1006912. PubMed ID: 28817564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis.
    Zeng X; Zhou J; Xiong Z; Sun H; Yang W; Mok MTS; Wang J; Li J; Liu M; Tang W; Feng Y; Wang HK; Tsang SW; Chow KL; Yeung PC; Wong J; Lai PB; Chan AW; To KF; Chan SL; Xia Q; Xue J; Chen X; Yu J; Peng S; Sung JJ; Kuang M; Cheng AS
    Cell Mol Immunol; 2021 Apr; 18(4):1005-1015. PubMed ID: 32879468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xylocydine, a novel Cdk inhibitor, is an effective inducer of apoptosis in hepatocellular carcinoma cells in vitro and in vivo.
    Cho SJ; Lee SS; Kim YJ; Park BD; Choi JS; Liu L; Ham YM; Moon Kim B; Lee SK
    Cancer Lett; 2010 Jan; 287(2):196-206. PubMed ID: 19616371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-related kinase regulates mammalian eye development through positive and negative regulation of the Hedgehog pathway.
    Lupu FI; Burnett JB; Eggenschwiler JT
    Dev Biol; 2018 Feb; 434(1):24-35. PubMed ID: 29166577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.